Nikhil Lalwani insider trades
Open-market stock purchases and sales by Nikhil Lalwani, PRESIDENT & CEO at ANI Pharmaceuticals Inc, from SEC Form 4 filings since Sep 8, 2020.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +166%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 15, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $388K |
| Sep 15, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $383K |
| Aug 25, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $401K |
| May 11, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $4.3M |
| Mar 7, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $1.3M |
| Feb 28, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $903K |
| Feb 26, 2026 | ANIP ANI Pharmaceuticals Inc | Bought (not open market) | $5.8M |
| Feb 14, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $797K |
| Feb 12, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $896K |
| Feb 11, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $2.3M |
Companies traded
- ANIP ANI Pharmaceuticals Inc: 1 buy, 12 sales, last Oct 15, 2026